Antoni Ribas

70PUBLICATIONS

399CO-AUTHORS

Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Get your video featured.

Publish with JoVE

Publications (70)

Sort by Publication Date:

|Jun 23, 2026

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|May 12, 2026

Whole-protein screening and multi-modal profiling of antigen-specific CD4<sup>+</sup> T cells at single-cell resolution.

|Apr 21, 2026

Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

|Apr 21, 2026

MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.

|Apr 15, 2026

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

|Feb 19, 2026

Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Grayson E Rodriguez, Yang Zhao, Yoko Nishiga

Pageof 12

Frequent Collaborators

12 joint publications

Katie M Campbell

Anusha Kalbasi

Bartosz Chmielowski

Egmidio Medina

Georgina V Long

Cristina Puig-Saus

Jia Ming Chen

Paolo Antonio Ascierto

7 joint publications

James R Heath

7 joint publications

Kari L Kendra

Frequent Collaborators

12 joint publications

Katie M Campbell

9 joint publications

Anusha Kalbasi

8 joint publications

Bartosz Chmielowski

8 joint publications

Egmidio Medina